Joint

Clinical Study Results Involving Spryng, a PetVivo Holdings, Inc. Product, Presented at the Veterinary Orthopedic Society Annual Conference in Lake Tahoe, California

Retrieved on: 
Thursday, February 29, 2024

Spryng™ with OsteoCuhsion™ Technology) into the coxofemoral joint of dogs with osteoarthritis.

Key Points: 
  • Spryng™ with OsteoCuhsion™ Technology) into the coxofemoral joint of dogs with osteoarthritis.
  • The microparticles of Spryng have been found to adsorb onto the joint synovial lining of animals and subsequently integrate with the animal’s subsynovial tissue.
  • The dogs enrolled in this study had been diagnosed with unilateral or bilateral coxofemoral joint osteoarthritis.
  • To view the abstract of the clinical study presented at the VOS annual conference please visit the following:

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Portfolio Execution

Retrieved on: 
Wednesday, February 28, 2024

HAMILTON, Bermuda, Feb. 28, 2024 (GLOBE NEWSWIRE) --  Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a commercial-stage biopharmaceutical company with a pipeline of immune-modulating assets designed to target a spectrum of cardiovascular and autoimmune diseases, today reported fourth quarter and full-year 2023 financial results and recent portfolio execution.

Key Points: 
  • Total revenue for the fourth quarter of 2023 was $83.4 million, compared to $61.9 million for the fourth quarter of 2022.
  • Total operating expenses for the fourth quarter of 2023 were $83.3 million, compared to $55.8 million for the fourth quarter of 2022.
  • Net income for the fourth quarter of 2023 was $25.2 million, compared to net income of $4.5 million for the fourth quarter of 2022.
  • Kiniksa will host a conference call and webcast at 8:30 a.m. Eastern Time on Wednesday, February 28, 2024, to discuss fourth quarter and full-year 2023 financial results and recent portfolio execution.

The Joint Corp. to Host Conference Call on Thursday, March 7th to Discuss Fourth Quarter and Year-end 2023 Results

Retrieved on: 
Thursday, February 22, 2024

SCOTTSDALE, Ariz., Feb. 22, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced it will report its fourth quarter and year-end 2023 financial results on Thursday, March 7, 2024, after the market close.

Key Points: 
  • SCOTTSDALE, Ariz., Feb. 22, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced it will report its fourth quarter and year-end 2023 financial results on Thursday, March 7, 2024, after the market close.
  • President and CEO Peter D. Holt and CFO Jake Singleton will hold a conference call at 5:00 p.m. EDT that day to discuss the results.
  • The live webcast of the call with accompanying slide presentation can be accessed in the IR events section https://ir.thejoint.com/events and available for approximately one year.
  • An audio archive can be accessed for one week by dialing (877) 344-7529 or (412) 317-0088 and entering conference ID 5448318.

Red Light Therapy At Home: A Comprehensive Beginner’s Guide

Retrieved on: 
Monday, February 19, 2024

However, many people are skeptical before using Red Light Therapy at their homes.

Key Points: 
  • However, many people are skeptical before using Red Light Therapy at their homes.
  • So, for such people, here is a guide that will tell you all that you need to know about Bestqool ’s Red Light Therapy devices.
  • Red Light Therapy, also known as Low-Level Laser Therapy or ‘photobiomodulation,’ is a form of therapeutic intervention that works by exposing a person’s skin or parts of the body to safe, low levels of red or near-infrared light.
  • In contrast to this, when Red Light Therapy is done in a professional’s office, it follows different protocols.

PK MED Announces FDA Clearance to Initiate Its Clinical Program for PKM-01, for Local Treatment of Gout Flares, Directly by a Phase 2 Trial

Retrieved on: 
Monday, February 26, 2024

During a Type B pre-IND meeting1, the Food and Drug Administration gave its clearance to directly initiate the clinical program for PKM-01 with a phase 2 trial for gout patients, without undertaking phase 1 studies.

Key Points: 
  • During a Type B pre-IND meeting1, the Food and Drug Administration gave its clearance to directly initiate the clinical program for PKM-01 with a phase 2 trial for gout patients, without undertaking phase 1 studies.
  • PKM-01 is a local intra-articular injection treatment for gout flares, developed by PK MED, aiming to provide a fast an effective pain relief and powerful and safe anti-inflammatory effect.
  • Thanks to its low-risk toxicity profile, PKM-01's clinical program will start directly in phase 2, which should considerably speed up time-to-market.
  • PK MED is now entering the fund-raising phase to finance PKM-01 phase 2 clinical trials.

Soul Community Planet Hotels Celebrates Classic California Cool with the Opening of Laguna Surf Lodge in Laguna Beach

Retrieved on: 
Thursday, March 7, 2024

LAGUNA BEACH, Calif., March 7, 2024 /PRNewswire-PRWeb/ -- Soul Community Planet (SCP) Hotels, a holistic hospitality company serving those who value wellness, social good and the environment, today announced the opening of the Laguna Surf Lodge by SCP, a classic, beachfront experience in one of California's most iconic destinations. Located in the heart of Laguna Beach, Calif., the 41-room eco surf lodge sits directly on the sand of the town's legendary beach, an easy walking distance to the acclaimed art galleries, eateries, and boutiques of Laguna Beach village. The hotel immerses guests in the nostalgia of California's fabled surf scene, while offering modern nature-based wellness experiences, locally sourced food and beverage, and SCP's signature Peaceful Rooms to ensure nothing but the sound of rolling waves and the ocean breeze stands in the way of complete relaxation.

Key Points: 
  • "A marriage of Laguna Beach's village character, California's surf culture and Soul Community Planet's healthy, kind and green ethos, the Laguna Surf Lodge by SCP is our ode to the unique vibe of Laguna Beach," said Soul Community Planet Founder and CEO Ken Cruse.
  • "A marriage of Laguna Beach's village character, California's surf culture and Soul Community Planet's healthy, kind and green ethos, the Laguna Surf Lodge by SCP is our ode to the unique vibe of Laguna Beach," said Soul Community Planet Founder and CEO Ken Cruse.
  • In short, the Laguna Surf Lodge by SCP is a place for those who celebrate all that makes Laguna Beach a paragon of cool."
  • Located directly on the beach in the heart of Laguna amidst the world-famous artist enclave, Laguna Surf Lodge offers an environmentally conscious retreat.

Rediscover Wellness with Z Natural Foods' Vanilla Vitality Blend Coffee Creamer, Enriched with 7 Mushrooms, Collagen, and MCT Oil

Retrieved on: 
Thursday, March 7, 2024

This new product is designed to elevate your coffee experience, featuring a unique blend of seven healthy mushrooms, collagen protein, and medium-chain triglycerides (MCT oil).

Key Points: 
  • This new product is designed to elevate your coffee experience, featuring a unique blend of seven healthy mushrooms, collagen protein, and medium-chain triglycerides (MCT oil).
  • Vitality Blend is more than just a coffee creamer; it's a powerhouse of natural ingredients carefully selected to enhance taste and health benefits.
  • Featuring seven mushrooms known for their immune-boosting and adaptogenic properties, Vitality Blend adds a new dimension to coffee and tea.
  • "We are excited to bring Vitality Blend to our customers," said Jonathan Parker, Director of Nutrition Sciences with Z Natural Foods.

MNA: Hospital Accrediting Agency (Joint Commission) Issues Findings Supporting St. Vincent Hospital Nurses' Complaints about Unsafe Patient Care, Stating that SVH was Found to Be Non-Compliant with Applicable Patient Care Conditions for Medicaid and Medic

Retrieved on: 
Wednesday, March 6, 2024

WORCESTER, Mass., March 6, 2024 /PRNewswire/ -- Nurses at St. Vincent Hospital, who have filed a number of official complaints and gone public with their serious concerns about patient care conditions that are harming patients at the Worcester-based facility, have had their claims validated by The Joint Commission, which conducted an investigation into the nurses complaints and found the hospital to be "non-compliant with applicable Centers for Medicaid and Medicare Services (CMS) Conditions."

Key Points: 
  • Your report was used to assist our team to better understand the organization's systems of providing care.
  • During the onsite review, the organization was found to be non-compliant with applicable Centers for Medicaid and Medicare Services (CMS) Conditions.
  • The complaints detailed a serious and ongoing degradation of care, which were based on more than 600 official reports filed by nurses over the last six months.
  • Founded in 1903, the Massachusetts Nurses Association is the largest union of registered nurses in the Commonwealth of Massachusetts.

Reticulate Micro Transmits First-ever Real-time Streaming Video over UHF TACSAT in Army Demonstration  

Retrieved on: 
Tuesday, March 5, 2024

PALM BAY, Fla., March 5, 2024 /PRNewswire/ -- Reticulate Micro, Inc., a defense technology company dedicated to delivering trusted and resilient communications over any transport and in any environment, announced today that it successfully streamed live video over a UHF TACSAT radio link – a first for the industry.

Key Points: 
  • Reticulate conducted the demonstration on Feb. 28th with the US Army, using Reticulate Micro's VAST™ encoder and NanTenna's Ultra High Frequency (UHF) TACSAT antenna.
  • It marked the first time a commercial provider has demonstrated live video streaming in a tactical environment over the Army's legacy TACSAT network.
  • Today, there is no other solution capable of streaming real-time video over legacy tactical networks such as HF and TACSAT," said John Dames, CTO of Reticulate Micro.
  • Reticulate will continue to do validations of its VAST video system across all tactical communication networks in use today and will make this data available to government customers.

Tevra Brands to Showcase New Pet Wellness and Behavioral Health Products at Booth #5464 During Global Pet Expo, March 20 - 22

Retrieved on: 
Monday, March 4, 2024

OMAHA, Neb., March 4, 2024 /PRNewswire-PRWeb/ -- Tevra Brands will exhibit at Global Pet Expo, the pet industry's premier event from March 20 to 22 in Orlando, and introduce a host of new products, headlined by five TWIST + LICK Well Gel solutions. Additionally, the brand will unveil a new answer to giving pills to discerning canines with the TWIST + LICK SimPill, as well as a full line of new Harmony Pet solutions that meet the calming needs of dogs and cats with proprietary, pheromone-activated products to deliver stress relieving results on the go.

Key Points: 
  • According to Caryn Stichler, vice president of marketing for Tevra Brands, "Tevra Brands empowers pet owners with solutions that work, and we take pride in developing groundbreaking products and delivery systems that go beyond traditional methods.
  • As a result, many pet owners are struggling to keep their beloved, four-legged family members in their homes.
  • Tevra Brands and their products help pet owners keep their fur-kids at home for the love, companionship and support they all cherish."
  • Visit booth #5464 at Global Pet Expo to see the entire line of T+L Well Gels, the new T+L SimPill and the Harmony product lines.